Abstract
Multiple sclerosis (MS) is a multifactorial, central nervous system, immune-mediated disease characterized by inflammation, demyelination, and neurodegeneration. Evidence suggests a steady rise in MS prevalence over the past five decades in the United States and around the world. Even with increased understanding of immunology, the specific etiological trigger of MS remains unknown. Evidence suggests that oxidative/nitroxidative stress is an important contributor to MS etiology, progression, and clinical symptoms. A multifaceted treatment approach aimed at counteracting oxidative/nitroxidative stress including MS disease–modifying medications, Mediterranean style diet, stress-relieving activities, smoking and alcohol cessation, exercise, and peer support programs is the best way to treat the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adamczyk-Sowa M, Pierzchala K, Sowa P, Mucha S, Sadowska-Bartosz I, Adamczyk J, Hartel M (2014) Melatonin acts as antioxidant and improves sleep in MS patients. Neurochem Res 39:1585–1593. https://doi.org/10.1007/s11064-014-1347-6
Adamczyk B, Adamczyk-Sowa M (2016) New insights into the role of oxidative stress mechanisms in the pathophysiology and treatment of multiple sclerosis. Oxidative Med Cell Longev 2016:1–18. https://doi.org/10.1155/2016/1973834
Adamczyk B, Niedziela N, Adamczyk-Sowa M (2017) Novel approaches of oxidative stress mechanisms in the multiple sclerosis pathophysiology and therapy, in: multiple sclerosis: perspectives in treatment and pathogenesis. Codon Publications, pp. 155–171. https://doi.org/10.15586/codon.multiplesclerosis.2017.ch10
Adelman G, Rane SG, Villa KF (2013) The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ 16:639–647. https://doi.org/10.3111/13696998.2013.778268
AlAmmar WA, Albeesh FH, Ibrahim LM, Algindan YY, Yamani LZ, Khattab RY (2019) Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci:1–11. https://doi.org/10.1080/1028415X.2019.1659560
Álvarez-Sánchez N, Cruz-Chamorro I, Díaz-Sánchez M, Sarmiento-Soto H, Medrano-Campillo P, Martínez-López A, Lardone PJ, Guerrero JM, Carrillo-Vico A (2017) Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients. J Pineal Res 63:e12442. https://doi.org/10.1111/jpi.12442
Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L (2001) Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler J 7:340–344. https://doi.org/10.1177/135245850100700511
Antel J, Antel S, Caramanos Z, Arnold DL, Kuhlmann T (2012) Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 123:627–638. https://doi.org/10.1007/s00401-012-0953-0
Armon-Omer A, Waldman C, Simaan N, Neuman H, Tamir S, Shahien R (2019) New insights on the nutrition status and antioxidant capacity in multiple sclerosis patients. Nutrients 11:427. https://doi.org/10.3390/nu11020427
Bagur MJ, Murcia MA, Jiménez-Monreal AM, Tur JA, Bibiloni MM, Alonso GL, Martínez-Tomé M (2017) Influence of diet in multiple sclerosis: a systematic review. Advances in Nutrition: An International Review Journal 8:463–472. https://doi.org/10.3945/an.116.014191
Biernacki T, Sandi D, Kincses ZT, Füvesi J, Rózsa C, Mátyás K, Vécsei L, Bencsik K (2019) Contributing factors to health-related quality of life in multiple sclerosis Brain and Behavior:9. https://doi.org/10.1002/brb3.1466
Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr K-M, Bø L (2012) Poor sleep in patients with multiple sclerosis. PLoS One 7:e49996. https://doi.org/10.1371/journal.pone.0049996
Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, Coleman R, Goldman MD (2019) Pilot study of a ketogenic diet in relapsing-remitting MS. Neurology - Neuroimmunology Neuroinflammation 6:e565. https://doi.org/10.1212/NXI.0000000000000565
Calabresi PA (2004) Diagnosis and management of multiple sclerosis. Am Fam Physician 70:1935–1944
Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Katz I, Gacias M, Zhu Y, Casaccia P, Cree BAC, Knight R, Mazmanian SK, Baranzini SE, Zhu Y (2017) Correction for "gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci 10:10713–10718. https://doi.org/10.1073/pnas.1711235114
Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 6:28484. https://doi.org/10.1038/srep28484
Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TP (1998) Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 88:45–56. https://doi.org/10.1016/S0165-5728(98)00078-2
Dardiotis E, Arseniou S, Sokratous M, Tsouris Z, Siokas V, Mentis AFA, Michalopoulou A, Andravizou A, Dastamani M, Paterakis K, Bogdanos D, Brotis A (2017) Vitamin B12, folate, and homocysteine levels and multiple sclerosis: a meta-analysis. Multiple Sclerosis and Related Disorders 17:190–197. https://doi.org/10.1016/j.msard.2017.08.004
De Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I.B., La Storia, A., Laghi, L.I, Serrazanetti, D., Di Cagno, R., Ferrocino, I., Lazzi, C., Turroni, S., Cocolin, L., Brigidi, P., Neviani, E., Gobbetti, M., O’Toole, P.W., Ercolini, D., 2016. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome Gut 65. https://doi.org/10.1136/gutjnl-2015-309957
Di Filippo M, Portaccio E, Mancini A, Calabresi P (2018) Multiple sclerosis and cognition: synaptic failure and network dysfunction. Nat Rev Neurosci 19:599–609. https://doi.org/10.1038/s41583-018-0053-9
Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478–489. https://doi.org/10.1002/ana.20736
Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, Danni M, Provinciali L (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler J 11:677–682. https://doi.org/10.1191/1352458505ms1240oa
Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, Van Horssen J, Lassmann H (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. A JOURNAL OF NEUROLOGY 135:886–899. https://doi.org/10.1093/brain/aws012
Fruewald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhacki U (2001) Depression and quality of life in multiple sclerosis. Acta Neurol Scand 104:257–261. https://doi.org/10.1034/j.1600-0404.2001.00022.x
Ghadirian, P., Jain, M., Ducic, S., Shatenstein, B., Morisset, R. (Epidemiology R.U.R.C.C.P.H.-D. 3850 rue S.U.M.Q.H. 1T8 (Canada)), 1998. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. International Journal of Epidemiology (United Kingdom)
Ghasemi N, Razavi S, Nikzad E (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 19:1–10. https://doi.org/10.22074/cellj.2016.4867
Gonsette RE (2008) Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 274:48–53. https://doi.org/10.1016/j.jns.2008.06.029
Gray E, Thomas TL, Betmouni S, Scolding N, Love S (2008) Elevated myeloperoxidase activity in white matter in multiple sclerosis. Neurosci Lett 444:195–198. https://doi.org/10.1016/j.neulet.2008.08.035
Haider L (2015) Inflammation. Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis 2015:1–10. https://doi.org/10.1155/2015/725370
Haider L, Fischer MT, Frischer JM, Bauer J, Hö R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. A JOURNAL OF NEUROLOGY 134:1914–1924. https://doi.org/10.1093/brain/awr128
Hajjar I, Hayek SS, Goldstein FC, Martin G, Jones DP, Quyyumi A (2018) Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study. J Neuroinflammation 15:17. https://doi.org/10.1186/s12974-017-1026-z
Hassan W, Noreen H, Castro-Gomes V, Mohammadzai I, da Rocha JBT, Landeira-Fernandez J (2016) Association of Oxidative Stress with Psychiatric Disorders. Curr Pharm Des 22:2960–2974
Hayes CE, Donald Acheson E (2008) A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Med Hypotheses 71:85–90. https://doi.org/10.1016/j.mehy.2008.01.031
Hughes, A.J., 2014. Glutathione as a predictor of neuropsychological impairment in patients with relapsing remitting, secondary progressive, and primary progressive multiple sclerosis
Jahromi SR, Toghae M, Jahromi MJR, Aloosh M (2012) Dietary pattern and risk of multiple sclerosis. Iranian journal of neurology 11:47–53
Katarina V, Gordana T, Svetlana MD, Milica B (2018) Oxidative stress and neuroinflammation should be both considered in the occurrence of fatigue and depression in multiple sclerosis. Acta Neurol Belg. https://doi.org/10.1007/s13760-018-1015-8
Katz Sand, I., Benn, E.K.T., Fabian, M., Fitzgerald, K.C., Digga, E., Deshpande, R., Miller, A., Gallo, S., Arab, L., 2019. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study Multiple Sclerosis and Related Disorders 36. https://doi.org/10.1016/j.msard.2019.101403
Khosravi-Largani M, Pourvali-Talatappeh P, Rousta AM, Karimi-Kivi M, Noroozi E, Mahjoob A, Asaadi Y, Shahmohammadi A, Sadeghi S, Shakeri S, Ghiyasvand K, Tavakoli-Yaraki M (2018) A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis. eNeurologicalSci 10:37–44 https://doi.org/10.1016/j.ensci.2018.01.007
Kim DY, Hao J, Liu R, Turner G, Shi F-D, Rho JM (2012) Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One 7:e35476. https://doi.org/10.1371/journal.pone.0035476
Kim HK, Park SK, Zhou J-L, Taglialatela G, Chung K, Coggeshall RE, Chung JM (2004) Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 111:116–124. https://doi.org/10.1016/j.pain.2004.06.008
Kuchling J, Ramien C, Bozin I, Dörr J, Harms L, Rosche B, Niendorf T, Paul F, Sinnecker T, Wuerfel J (2014) Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study. Mult Scler J 20:1866–1871. https://doi.org/10.1177/1352458514531084
Kulaklı F (2018) The effect of alpha lipoic acid in the treatment of multiple sclerosis induced neuropathic pain: a case report. Eurasian Journal of Medicine and Oncology. https://doi.org/10.14744/ejmo.2017.37929
Langer-Gould A, Brara SM, Beaber BE, Koebnick C (2013) Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 80:548–552. https://doi.org/10.1212/WNL.0b013e31828154f3
Lassmann H, van Horssen J (2016) Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim Biophys Acta Mol basis Dis 1862:506–510. https://doi.org/10.1016/j.bbadis.2015.09.018
Li J, Ma J, Lacagnina MJ, Lorca S, Odem MA, Walters ET, Kavelaars A, Grace PM (2020) Oral dimethyl fumarate reduces peripheral neuropathic pain in rodents via NFe2L2 antioxidant signaling. Anesthesiology 132:343–356. https://doi.org/10.1097/ALN.0000000000003077
Li S, Vana AC, Ribeiro R, Zhang Y (2011) Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis. Neuroscience 184:107–119. https://doi.org/10.1016/j.neuroscience.2011.04.007
Little JW, Doyle T, Salvemini D (2012) Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain. Amino Acids 42:75–94. https://doi.org/10.1007/s00726-010-0633-0
Lu F, Selak M, O’Connor J, Croul S, Lorenzana C, Butunoi C, Kalman B (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177:95–103. https://doi.org/10.1016/S0022-510X(00)00343-9
Maas DA, Vallès A, Martens GJM (2017) Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry 7:e1171. https://doi.org/10.1038/tp.2017.138
Mao P, Reddy PH (2010) Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta (BBA) - Mol Basis Dis 1802:66–79. https://doi.org/10.1016/J.BBADIS.2009.07.002
Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, Serafini A, Dolso P, Gigli GL (2009) Prevalence of “poor sleep” among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 10:26–34. https://doi.org/10.1016/j.sleep.2007.11.004
Miller E, Walczak A, Majsterek I, Kędziora J (2013) Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol 257:97–101. https://doi.org/10.1016/j.jneuroim.2013.02.012
Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M (2019) A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis. Nutrients. 11. https://doi.org/10.3390/nu11071528
Moccia M, Capacchione A, Lanzillo R, Carbone F, Micillo T, Perna F, De Rosa A, Carotenuto A, Albero R, Matarese G, Palladino R, Brescia Morra V (2019) Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis. Ther Adv Neurol Disord 12:1756286418819074. https://doi.org/10.1177/1756286418819074
Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB (2016) Obesity and multiple sclerosis: a Mendelian randomization study. PLoS Med 13:e1002053. https://doi.org/10.1371/journal.pmed.1002053
Moniczewski A, Gawlik M, Smaga I, Niedzielska E, Krzek J, Przegaliński E, Pera J, Filip M (2015) Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol Rep 67:560–568. https://doi.org/10.1016/j.pharep.2014.12.014
Monti DA, Zabrecky G, Leist TP, Wintering N, Bazzan AJ, Zhan T, Newberg AB (2020) N-acetyl cysteine administration is associated with increased cerebral glucose metabolism in patients with multiple sclerosis: an exploratory study. Front Neurol 11:88. https://doi.org/10.3389/fneur.2020.00088
Morris G, Reiche EMV, Murru A, Carvalho AF, Maes M, Berk M, Puri BK (2018a) Multiple immune-inflammatory and oxidative and Nitrosative stress pathways explain the frequent presence of depression in multiple sclerosis. Mol Neurobiol 55:6282–6306. https://doi.org/10.1007/s12035-017-0843-5
Morris G, Stubbs B, Köhler CA, Walder K, Slyepchenko A, Berk M, Carvalho AF (2018b) The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev 41:255–265. https://doi.org/10.1016/j.smrv.2018.03.007
Motl RW, Gosney JL (2008) Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult Scler J 14:129–135. https://doi.org/10.1177/1352458507080464
Murphy KL, Bethea JR, Fischer R (2017a) Neuropathic pain in multiple sclerosis–current therapeutic intervention and future treatment perspectives, in: multiple sclerosis: perspectives in treatment and pathogenesis. Codon Publications, pp. 53–69. https://doi.org/10.15586/codon.multiplesclerosis.2017.ch4
Murphy R, O’Donoghue S, Counihan T, McDonald C, Calabresi PA, Ahmed MA, Kaplin A, Hallahan B (2017b) Neuropsychiatric syndromes of multiple sclerosis. J Neurol Neurosurg Psychiatry 88:697–708. https://doi.org/10.1136/JNNP-2016-315367
Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851–876. https://doi.org/10.1017/S1461145707008401
Ng L, Amatya B, Khan F (2013) Outcomes of a peer support program in multiple sclerosis in an Australian community cohort: a prospective study. Journal of Neurodegenerative Diseases 2013:1–7
Nikić I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Brück W, Bishop D, Misgeld T, Kerschensteiner M (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495–499. https://doi.org/10.1038/nm.2324
Ochoa-Reparaz J, Magori K, Kasper LH (2017) The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis. Annals of Translational Medicine 5:145. https://doi.org/10.21037/atm.2017.01.18
Ortiz GG, Pacheco-Moisés FP, Bitzer-Quintero OK, Ramírez-Anguiano AC, Flores-Alvarado LJ, Ramírez-Ramírez V, Macias-Islas MA, Torres-Sánchez ED (2013) Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clinical & developmental immunology 2013:708659–708614. https://doi.org/10.1155/2013/708659
Park CW, Macinnis DJ, Priester J, Eisingerich AB, Iacobucci D (2010) Brand attachment and brand attitude strength: conceptual and empirical differentiation of two critical brand equity drivers. J Mark 74:1–17
Park E-S, Gao X, Chung JM, Chung K (2006) Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons. Neurosci Lett 391:108–111. https://doi.org/10.1016/j.neulet.2005.08.055
Pilutti LA, Greenlee TA, Motl RW, Nickrent MS, Petruzzello SJ (2013) Effects of exercise training on fatigue in multiple sclerosis. Psychosom Med 75:575–580. https://doi.org/10.1097/PSY.0b013e31829b4525
Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 281:31950–31962. https://doi.org/10.1074/jbc.M603717200
Rao SM (1995) Neuropsychology of multiple sclerosis. Curr Opin Neurol 8:216–220. https://doi.org/10.1097/00019052-199506000-00010
Rosenberg GA (2002) Matrix metalloproteinases and neuroinflammation in multiple sclerosis. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 8:586–595. https://doi.org/10.1177/1073858402238517
Salim S (2014) Oxidative stress and psychological disorders. Curr Neuropharmacol 12:140–147. https://doi.org/10.2174/1570159X11666131120230309
Salvemini D, Little JW, Doyle T, Neumann WL (2011) Roles of reactive oxygen and nitrogen species in pain. Free Radic Biol Med 51:951–966. https://doi.org/10.1016/j.freeradbiomed.2011.01.026
Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F (2016) Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci 19:138–143. https://doi.org/10.1179/1476830515Y.0000000002
Schepici G, Silvestro S, Bramanti P, Mazzon E (2019) The gut microbiota in multiple sclerosis: an overview of clinical trials. Cell Transplant 28:1507–1527. https://doi.org/10.1177/0963689719873890
Sedaghat F, Jessri M, Behrooz M, Mirghotbi M, Rashidkhani B (2016) Mediterranean diet adherence and risk of multiple sclerosis: a case-control study. Asia Pac J Clin Nutr 25:377–384. https://doi.org/10.6133/apjcn.2016.25.2.12
Shohani, M., Kazemi, F., Rahmati, S., Azami, M., 2020. The effect of yoga on the quality of life and fatigue in patients with multiple sclerosis: A systematic review and meta-analysis of randomized clinical trials Complementary Therapies in Clinical Practice 39. https://doi.org/10.1016/j.ctcp.2020.101087
Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15:73. https://doi.org/10.1186/s12967-017-1175-y
Siniscalco D, Fuccio C, Giordano C, Ferraraccio F, Palazzo E, Luongo L, Rossi F, Roth K, Maione S, Denovellis V (2007) Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain. Pharmacol Res 55:158–166. https://doi.org/10.1016/j.phrs.2006.11.009
Siotto M, Filippi MM, Simonelli I, Landi D, Ghazaryan A, Vollaro S, Ventriglia M, Pasqualetti P, Rongioletti MCA, Squitti R, Vernieri F (2019) Oxidative stress related to Iron metabolism in relapsing remitting multiple sclerosis patients with low disability. Front Neurosci 13:86. https://doi.org/10.3389/fnins.2019.00086
Skokou M, Soubasi E, Gourzis P (2012) Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. International scholarly research network ISRN neurology 2012. https://doi.org/10.5402/2012/427102
Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegaliński E, Pera J, Filip M (2015) Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep 67:569–580. https://doi.org/10.1016/J.PHAREP.2014.12.015
Smith KJ, Kapoor R, Felts PA (2006) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9:69–92. https://doi.org/10.1111/j.1750-3639.1999.tb00212.x
Solaro C, Messmer Uccelli M (2011) Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol 7:519–527. https://doi.org/10.1038/nrneurol.2011.120
Solaro C, Trabucco E, Messmer Uccelli M (2013) Pain and multiple sclerosis: pathophysiology and treatment topical collection on demyelinating disorders. Current Neurology and Neuroscience Reports 13:1–9. https://doi.org/10.1007/s11910-012-0320-5
Spain R, Powers K, Murchison C, Heriza E, Winges K, Yadav V, Cameron M, Kim E, Horak F, Simon J, Bourdette D (2017) Lipoic acid in secondary progressive MS. Neurology: Neuroimmunology and NeuroInflammation 4:e374. https://doi.org/10.1212/NXI.0000000000000374
Storoni M, Plant GT (2015) The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis. Mult Scler Int 2015:681289–681289. https://doi.org/10.1155/2015/681289
Su K, Bourdette D, Forte M (2013) Mitochondrial dysfunction and neurodegeneration in multiple sclerosis. Front Physiol 4:169. https://doi.org/10.3389/fphys.2013.00169
Tarbali S, Khezri S (2016) Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination. Iranian Journal of Basic Medical Sciences 19:80–88. https://doi.org/10.22038/ijbms.2016.6418
Tavee J, Rensel M, Planchon SM, Butler RS, Stone L (2011) Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy. International Journal of MS Care 13:163–168. https://doi.org/10.7224/1537-2073-13.4.163
Teixeira KRC, dos Santos CP, de Medeiros LA, Mendes JA, Cunha TM, De Angelis K, Penha-Silva N, de Oliveira EP, Crispim CA (2019) Night workers have lower levels of antioxidant defenses and higher levels of oxidative stress damage when compared to day workers. Sci Rep 9:1–11. https://doi.org/10.1038/s41598-019-40989-6
Tobore TO (2019) On elucidation of the role of mitochondria dysfunction and oxidative stress in multiple sclerosis. Neurology and Clinical Neuroscience 7:305–317. https://doi.org/10.1111/ncn3.12335
Tobore TO (2020a) Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis. International journal of neuroscience 130. https://doi.org/10.1080/00207454.2019.1677648
Tobore TO (2020b) Towards a comprehensive theory of obesity and a healthy diet: the causal role of oxidative stress in food addiction and obesity. Behav Brain Res 384:112560. https://doi.org/10.1016/j.bbr.2020.112560
Tsaluchidu S, Cocchi M, Tonello L, Puri BK (2008) Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 8:S5. https://doi.org/10.1186/1471-244X-8-S1-S5
van de Lagemaat EE, de Groot LCPGM, van den Heuvel EGHM (2019) Vitamin B 12 in relation to oxidative stress: a systematic review. Nutrients. 11. https://doi.org/10.3390/nu11020482
Villafuerte, G., Miguel-Puga, A., Murillo Rodríguez, E., Machado, S., Manjarrez, E., Arias-Carrión, O., 2015. Sleep deprivation and oxidative stress in animal Models: A Systematic Review. https://doi.org/10.1155/2015/234952
Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyová I, Mikula P, Krokavcova M, Groothoff JW, Van Dijk JP (2014) Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Disability and Health Journal 7:466–471. https://doi.org/10.1016/j.dhjo.2014.05.004
Vitkova M, Rosenberger J, Gdovinova Z, Szilasiova J, Mikula P, Groothoff JW, Reijneveld SA, van Dijk JP (2016) Poor sleep quality in patients with multiple sclerosis: gender differences. Brain and Behavior 6:e00553. https://doi.org/10.1002/brb3.553
Vladimirova, O., O’Connor, J., Cahill, A., Alder, H., Butunoi, C., Kalman, B., 1998. Oxidative damage to DNA in plaques of MS brains. Multiple sclerosis (Houndmills, Basingstoke, England) 4, 413–8. https://doi.org/10.1177/135245859800400503
Vyshkina T, Sylvester A, Sadiq S, Bonilla E, Canter JA, Perl A, Kalman B (2008) Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus. Clin Immunol 129:31–35. https://doi.org/10.1016/j.clim.2008.07.011
Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, Larocca NG (2019) The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology 92:E1029–E1040. https://doi.org/10.1212/WNL.0000000000007035
Wang P, Xie K, Wang C, Bi J (2014) Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and Neurodegeneration in multiple sclerosis. Eur Neurol 72:249–254. https://doi.org/10.1159/000363515
Weinshenker BG (1996) Epidemiology of multiple sclerosis. Neurol Clin 14:291–308
White LJ, Castellano V (2008) Exercise and brain health ??? Implications for multiple sclerosis. Sports Med 38:91–100. https://doi.org/10.2165/00007256-200838020-00001
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105–108. https://doi.org/10.1126/science.1208344
Yadav V, Marracci G, Lovera J, Woodward W, Bogardus K, Marquardt W, Shinto L, Morris C, Bourdette D (2005) Lipoic acid in multiple sclerosis: a pilot study. Mult Scler J 11:159–165. https://doi.org/10.1191/1352458505ms1143oa
Yowtak J, Lee KY, Kim HY, Wang J, Kim HK, Chung K, Chung JM (2011) Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 152:844–852. https://doi.org/10.1016/j.pain.2010.12.034
Yowtak J, Wang J, Kim HY, Lu Y, Chung K, Chung JM (2013) Effect of antioxidant treatment on spinal GABA neurons in a neuropathic pain model in the mouse. Pain 154:2469–2476. https://doi.org/10.1016/j.pain.2013.07.024
Yu X, Koczan D, Sulonen AM, Akkad DA, Kroner A, Comabella M, Costa G, Corongiu D, Goertsches R, Camina-Tato M, Thiesen HJ, Nyland HI, Mørk SJ, Montalban X, Rieckmann P, Marrosu MG, Myhr KM, Epplen JT, Saarela J, Ibrahim SM (2008) mtDNA nt13708A variant increases the risk of multiple sclerosis. PLoS ONE 3. https://doi.org/10.1371/journal.pone.0001530
Zwibel, H.L., Smrtka, J., 2011. Improving quality of life in multiple sclerosis: an unmet need. The American journal of managed care 17 Suppl 5 improving, S139-45
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
On behalf of all authors, the corresponding author states that there is no conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Tobore Onojighofia Tobore: Independent scholar.
Rights and permissions
About this article
Cite this article
Tobore, T.O. Oxidative/Nitroxidative Stress and Multiple Sclerosis. J Mol Neurosci 71, 506–514 (2021). https://doi.org/10.1007/s12031-020-01672-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01672-y